June 14, 2024 – Abbott proclaims approval from the U.S. Meals and Drug Administration (FDA) for 2 new over-the-counter steady glucose monitoring (CGM) programs – Lingo™ and Libre Rio™, that are based mostly on Abbott's industry-leading FreeStyle Libre® expertise for steady glucose monitoring, which is now utilized by roughly 6 million folks worldwide. The newly permitted programs […]